Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-06-06 | New | $49,999,926 | $49,999,926 | Equity Only | 06b | SEC link |
| 2023-09-12 | New | $22,285,675 | $22,285,675 | Equity Only | 06b | SEC link |
| 2021-12-30 | New | $30,248,730 | $30,248,730 | Equity Only | 06b | SEC link |
| 2021-01-12 | Amended | $2,000,000 | $535,000 | Debt Only | 06b | SEC link |
| 2020-11-23 | New | $1,465,000 | $1,465,000 | Debt Only | 06b | SEC link |
| 2018-04-06 | New | $7,412,261 | $7,412,261 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| David Cash | Director |
| Judson Cooper | Director |
| Brian De Beaubien | Director |
| Douglas Kohrs | Director |
| Noam Krantz | Director |
| Rushu Luo | Director |
| Biren Mehta | Director |
| Jude Paganelli | Director, Executive |
| Sonal Patel | Director |
| Renee Ryan | Director |
| Martin Sands | Director |
| David Thompson | Director, Executive |